Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products and services as follows:
- pet medications (60.9%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips;
- livestock medications (37.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc.;
- other (1.8%): mainly fabrication services for third parties.
At the end of 2012, the group had 7 production sites in the world.Net sales break down geographically as follows: France (19%), Europe (27.3%), North America (15.8%), Asia (12.7%), Pacific (12.7%), Latin America (9%), Africa and Middle East (3.5%).